共 50 条
- [1] Why the product labeling for low-dose vaginal estrogen should be changed MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2014, 21 (09): : 911 - 916
- [2] Urogenital atrophy and low-dose vaginal estrogen therapy MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2000, 7 (03): : 140 - 142
- [3] Systemic Estradiol Levels with Low-Dose Vaginal Estrogens May Differ by Dose and by Product MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2018, 25 (12): : 1505 - 1505
- [4] Estrogen and stroke: a case for low-dose estrogen MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2006, 13 (05): : 719 - 720
- [5] The sexual health benefits of oral low-dose estrogen plus progestogen and vaginal estrogen for postmenopausal women MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2009, 16 (02): : 224 - 225
- [9] Initial observations describing a lack of endometrial estrogenicity in response to low-dose estrogen vaginal implants MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2021, 28 (09): : 969 - 970
- [10] LOW-DOSE PROPHYLACTIC ANTIBIOTICS IN VAGINAL HYSTERECTOMY OBSTETRICS AND GYNECOLOGY, 1974, 43 (03): : 379 - 385